All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.
Primary tabs
Focus on
Medication review and deprescribingThe increase in life expectancy and the growing availability of effective drugs for the management of chronic diseases are leading to an increase in the number of patients, suffering of multimorbidity, in polypharmacotherapy (regular intake of at least five...
Columns
Drugs & Elderly
In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention...
From regulatory agencies
| 04 August 2026 FDA | 04 August 2026 FDA |
| 03 August 2026 FDA | 03 August 2026 FDA |
| 03 August 2026 FDA | 03 August 2026 FDA |
| 31 July 2026 FDA | 30 July 2026 FDA |
| 27 July 2026 FDA | 24 July 2026 FDA |